ImExHS Ltd
ASX:IME
ImExHS Ltd
ASX:IME
Price:
0.57 AUD
4.59%
Market Closed
Updated:
Apr 29, 2024
Section:
Relative Value
The Relative Value of one
IME
stock under the Base Case scenario is
0.93
AUD.
Compared to the current market price of 0.57 AUD,
ImExHS Ltd
is
Undervalued by 39%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
IME
Relative Value
Base Case
0.93
AUD
Undervaluation 39%
Valuation Multiples
Multiples Across Competitors
IME Competitors Multiples
ImExHS Ltd Competitors
ImExHS Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| AU |
|
ImExHS Ltd
ASX:IME
|
24.3m AUD | 1.2 | -5.8 | -170.7 | -8.7 | |
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
32.4B USD | 13.7 | 61.6 | 61.4 | 66.1 | |
| US |
|
Cerner Corp
NASDAQ:CERN
|
27.9B USD | 4.8 | 47.3 | 19.6 | 38.6 | |
| US |
|
Change Healthcare Inc
NASDAQ:CHNG
|
9B USD | 2.6 | -116.8 | 16.5 | 111.6 | |
| JP |
|
M3 Inc
TSE:2413
|
1.3T JPY | 5.4 | 27.5 | 14.6 | 16.4 | |
| AU |
|
Pro Medicus Ltd
ASX:PME
|
11.4B AUD | 78.1 | 163.9 | 112.7 | 112.7 | |
| US |
|
Inspire Medical Systems Inc
NYSE:INSP
|
7B USD | 11.2 | -331.8 | -175.3 | -162.9 | |
| US |
|
Doximity Inc
NYSE:DOCS
|
4.4B USD | 9.5 | 32.2 | 21.5 | 22.9 | |
| SE |
|
Sectra AB
STO:SECT B
|
42.7B SEK | 25.7 | 99.1 | -66.2 | -66.2 | |
| US |
|
Evolent Health Inc
NYSE:EVH
|
3.1B USD | 1.6 | -22.1 | 26.1 | 277.7 | |
| US |
|
Goodrx Holdings Inc
NASDAQ:GDRX
|
2.8B USD | 3.8 | -319.5 | 34.1 | -111.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
